Paul Peter Tak, M.D.

Paul Peter Tak, M.D.

Ph.D., FMedSci, Chief Executive OfficeratCandel Therapeutics· In proxies 2022–2025

Paul Peter Tak, M.D. is CEO of Candel Therapeutics.

Experience

  1. Candel TherapeuticsPublic company · 4 yr
    • Ph.D., FMedSci, Chief Executive Officer2022 – Present · 4 yrStock in role +11%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?